Stockscreener 앱 받기
2.30
24.92%
-0.75
전일 마감가:
$3.05
열려 있는:
$3.05
하루 거래량:
752.22K
Relative Volume:
4.15
시가총액:
$84.88M
수익:
-
순이익/손실:
$-8.82M
주가수익비율:
-7.6667
EPS:
-0.3
순현금흐름:
$-18.01M
1주 성능:
-7.29%
1개월 성능:
+74.81%
6개월 성능:
+97.41%
1년 성능:
+192.65%
1일 변동 폭
$2.155
$3.15
1주일 범위
$2.155
$3.15
52주 변동 폭
$0.6951
$3.15
Estrella Immunopharma Inc Stock (ESLA) Company Profile
명칭
Estrella Immunopharma Inc
전화
(510) 318-9098
주소
5858 HORTON STREET, SUITE 370, EMERYVILLE
ESLA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ESLA
Estrella Immunopharma Inc
|
2.29 | 113.05M | 0 | -8.82M | -18.01M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.25 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
631.09 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
425.06 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.92 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.68 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Estrella Immunopharma Inc 주식(ESLA)의 최신 뉴스
Estrella Immunopharma's (ESLA) "Buy" Rating Reaffirmed at D. Boral Capital - MarketBeat
Check out these key findings about Estrella Immunopharma Inc (ESLA) - setenews.com
What data driven models say about Estrella Immunopharma Inc.’s future2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com
Estrella Immunopharma (NASDAQ:ESLA) Given “Buy” Rating at D. Boral Capital - Defense World
Estrella Immunopharma stock soars after 100% complete response rate in trial - Investing.com Australia
Analyst Jason Kolbert Maintains Buy Rating on ESLA | ESLA Stock News - GuruFocus
Estrella Immunopharma Completes Second Dose Cohort in STARLIGHT-1 Trial of EB103 with Complete Responses in All Evaluable Patients - The Joplin Globe
Is Estrella Immunopharma Inc. building a consolidation base2025 Market Outlook & AI Forecasted Entry/Exit Points - newser.com
Is Estrella Immunopharma Inc. stock ready for breakoutWeekly Trade Review & Long-Term Capital Growth Ideas - newser.com
Is now a turning point for Estrella Immunopharma Inc.Quarterly Portfolio Summary & Growth-Oriented Investment Plans - newser.com
Is Estrella Immunopharma Inc. reversing from oversold territoryQuarterly Profit Summary & Expert Verified Movement Alerts - newser.com
How to integrate Estrella Immunopharma Inc. into portfolio analysis tools2025 Year in Review & Fast Exit and Entry Strategy Plans - newser.com
Will Estrella Immunopharma Inc. stock gain from government policiesSell Signal & Weekly Return Optimization Plans - newser.com
What indicators show strength in Estrella Immunopharma Inc.2025 Valuation Update & Daily Chart Pattern Signals - newser.com
Leading vs lagging indicators on Estrella Immunopharma Inc. performanceLayoff News & Safe Entry Point Alerts - newser.com
Using data models to predict Estrella Immunopharma Inc. stock movementPortfolio Profit Report & Verified Swing Trading Watchlists - newser.com
Estrella Immunopharma (NASDAQ:ESLA) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
Estrella Immunopharma, Inc. (ESLA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
What analysts say about Estrella Immunopharma Inc stockReal Estate Investment Trusts & Low Risk Trading Portfolio - earlytimes.in
Will Estrella Immunopharma Inc. stock benefit from commodity prices2025 Earnings Impact & Free Community Consensus Stock Picks - fcp.pa.gov.br
Published on: 2025-10-28 05:18:37 - newser.com
Published on: 2025-10-27 06:57:23 - newser.com
Estrella Immunopharma Inc (ESLA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.02%
0.86%
자본화:
|
볼륨(24시간):